Greig, Iain R.Baillie, Gemma L.Abdelrahman, Mostafa HamedTrembleau, LaurentRoss, Ruth A.2017-08-102017-08-102016-09-15Greig, I R, Baillie, G L, Abdelrahman, M H, Trembleau, L & Ross, R A 2016, 'Development of indole sulfonamides as cannabinoid receptor negative allosteric modulators', Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 18, pp. 4403-4407. https://doi.org/10.1016/j.bmcl.2016.08.0180960-894XORCID: /0000-0003-0603-3383/work/65549953ORCID: /0000-0001-6376-9077/work/72631850http://hdl.handle.net/2164/9117This Letter was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) and the Scottish Universities Life Sciences Alliance (SULSA) in 20115477812engcannabinoidnegative allosteric modulatorCB1NAMindole sulfonamideRS Pharmacy and materia medicaBiotechnology and Biological Sciences Research Council (BBSRC)RSDevelopment of indole sulfonamides as cannabinoid receptor negative allosteric modulatorsJournal article10.1016/j.bmcl.2016.08.0182618